Prediction of mortality and survival of patients with acute myelogenous leukaemia in the intensive care unit - a single center experience

Pohlen M, Thoennissen NH, Hullermann C, Thoennissen GB, Oberfeld J, Lebiedz P, Waltenberger J, Krug U, Berdel WE (2012)

In: Medizinische Klinik - Intensivmedizin und Notfallmedizin, 107(4).

Forschungsartikel (Zeitschrift)

Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia

Müller-Tidow C, Klein HU, Hascher A, Isken F, Tickenbrock L, Thoennissen N, Agrawal-Singh S, Tschanter P, Disselhoff C, Wang Y, Becker A, Thiede C, Ehninger G, zur Stadt U, Koschmieder S, Seidl M, Müller FU, Schmitz W, Schlenke P, McClelland M, Berdel WE, Dugas M, Serve H, Study Alliance Leukemia (2010)

In: Blood, 116(18).

Forschungsartikel (Zeitschrift)

Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms.

Thoennissen NH, Krug UO, Lee DH, Kawamata N, Iwanski GB, Lasho T, Weiss T, Nowak D, Koren-Michowitz M, Kato M, Sanada M, Shih LY, Nagler A, Raynaud SD, Müller-Tidow C, Mesa R, Haferlach T, Gilliland DG, Tefferi A, Ogawa S, Koeffler HP (2010)

In: Blood, 115(14).

Forschungsartikel (Zeitschrift)

Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.

In: .

In vivo deficiency of both C/EBP? and C/EBP? results in highly defective myeloid differentiation and lack of cytokine response.

In: .

Publikationen

Betrieben von

Top-Links

Prediction of mortality and survival of patients with acute myelogenous leukaemia in the intensive care unit - a single center experience Pohlen M, Thoennissen NH, Hullermann C, Thoennissen GB, Oberfeld J, Lebiedz P, Waltenberger J, Krug U, Berdel WE (2012) In: Medizinische Klinik - Intensivmedizin und Notfallmedizin, 107(4). Forschungsartikel (Zeitschrift)
POEMS syndrome treated with melphalan high-dose therapy and autologous blood stem cell transplantation: a single-institution experience. Thoennissen GB, Thoennissen NH, Fritz F, Hilbig A, Kerkhoff A, Liersch R, Krug U, Koschmieder S, Müller-Tidow C, Mesters R, Kropff M, Berdel WE (2012) In: Annals of Hematology, 91(9). Forschungsartikel (Zeitschrift)
Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia Müller-Tidow C, Klein HU, Hascher A, Isken F, Tickenbrock L, Thoennissen N, Agrawal-Singh S, Tschanter P, Disselhoff C, Wang Y, Becker A, Thiede C, Ehninger G, zur Stadt U, Koschmieder S, Seidl M, Müller FU, Schmitz W, Schlenke P, McClelland M, Berdel WE, Dugas M, Serve H, Study Alliance Leukemia (2010) In: Blood, 116(18). Forschungsartikel (Zeitschrift)
Pim2 cooperates with PML-RARalpha to induce acute myeloid leukemia in a bone marrow transplantation model. Agrawal-Singh S, Koschmieder S, Gelsing S, Stocking C, Stehling M, Thiede C, Thoennissen NH, Köhler G, Valk PJ, Delwel R, Mills K, Bäumer N, Tickenbrock L, Hansen K, Berdel WE, Müller-Tidow C, Serve H (2010) In: Blood, 115(22). Forschungsartikel (Zeitschrift)
Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms. Thoennissen NH, Krug UO, Lee DH, Kawamata N, Iwanski GB, Lasho T, Weiss T, Nowak D, Koren-Michowitz M, Kato M, Sanada M, Shih LY, Nagler A, Raynaud SD, Müller-Tidow C, Mesa R, Haferlach T, Gilliland DG, Tefferi A, Ogawa S, Koeffler HP (2010) In: Blood, 115(14). Forschungsartikel (Zeitschrift)
SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations. Nowak D, Ogawa S, Müschen M, Kato M, Kawamata N, Meixel A, Nowak V, Kim HS, Kang S, Paquette R, Chang MS, Thoennissen NH, Thoenissen NH, Mossner M, Hofmann WK, Kohlmann A, Weiss T, Haferlach T, Haferlach C, Koeffler HP (2010) In: .
Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway. In: .
Cucurbitacin: ancient compound shedding new light on cancer treatment. In: .
In vivo deficiency of both C/EBP? and C/EBP? results in highly defective myeloid differentiation and lack of cytokine response. In: .
Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells. In: .